Primary prevention of breast cancer: New approaches

	Tweet

Lifestyle changes, such as exercise, might reduce the risk of breast cancer. Tamoxifen and raloxifene reduce the risk of breast cancer but have potential adverse effects and, therefore, should be considered by women at high risk of breast cancer. 

Breast density is a strong risk factor for breast cancer; assessment of breast density can be combined with risk factors to estimate a woman’s risk of breast cancer.

Breast cancer: Are oestrogen metabolites carcinogenic?

The World Health Organization (WHO) classified oestrogens as carcinogenic in humans. One of the main arguments has been that oestrogens not only can promote cancers but also may initiate mutations caused by certain oestrogen metabolites. Indeed there is evidence that they can have biological properties even at very low concentrations which can exceed manifold those of their parent substance. Highly sophisticated laboratory methods will allow us to understand oestrogenic effects as a net effect of the corresponding metabolite pattern.

Current research focuses on the possible carcinogenic properties of 4-hydroxyoestrogens and 16-alpha-hydroxyoestrone, but also on the anticancerogenic effects particularly of 2-methoxyoestradiol. Thus, potential toxic secondary metabolites like 4-quinones can be eliminated, e.g. by methylation. 2-methoxyoestradiol is a potent antiproliferative and antiangiogenic metabolite, and is currently tested in patients with refractory metastatic breast cancer. Observational trials have demonstrated that the ratio of 2- to 16-alpha-hydroxyoestrone is decreased in women with breast cancer. We have been able to demonstrate that oestradiol metabolism during HRT can be influenced by administration route, possibly also by certain progestogens.

In in vitro and animal experiments certain oestrogen metabolites indeed can act as carcinogens. However, since for the formation of these metabolites the appearance of very special conditions is a prerequisite and also various protective mechanisms are present, this might only contribute to breast carcinogenesis in very rare cases. However, the clinical relevance remains unclear and it appears to be important to ascertain this issue.

Steven R. Cummings
San Francisco Coordinating Center, California Pacific Medical Center Research Institute and the University of California, San Francisco, CA, United States
Tel.: +1 415 203 2864

RELATED STORIES:
Not all women complete radiation for breast cancer   Study aims to find which breast cancer patients need chemotherapy   Drug May Combat Weight Loss During Radiation Treatments   ACE Inhibitors May Increase Risk of Recurrence in Breast Cancer Survivors   IOM Report On Breast Cancer And The Environment   Over-the-counter anesthetic gel puts the squeeze on mammogram pain   3-week radiation therapy as effective as 5 weeks for early-stage breast cancer   Liposuction: A source for breast augmentation?   Breast Cancer: What is an “early Stage” Breast Cancer   Study Suggests Mastectomy Not Being Overused For Breast Cancer Treatment   Molecules can block breast cancer’s ability to spread   Smoking not linked to more advanced breast cancer   Using PET/CT in the Detection of Breast Cancer Metastases   Genes Linked to Breast Cancer Drug Resistance Could Guide Future Treatment   Estrogen therapy linked to benign breast disease   Breast Cancer Risk Found High After Chest Radiation for Hodgkin’s   Broken genomes behind breast cancers   Even After Surgery, Women Remain Unsure of Breast Cancer Survival Rates   Singling out the real breast cancer among the lumps   Wet ear wax and unpleasant body odors signal breast cancer risk   Study finds side effects, complications, mastectomy more likely after partial breast irradiation   Manchester researchers announce new methods of beating breast cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]